Â
How will life sciences look like in - let's say - 2030? What are sustainable and future business models for biotech companies and investors? How will the global workforce change and how can companies prepare for future talent? Which global regions and cities will be leading in innovation and why? These and other questions about how the life sciences industry is shaping the future will be the topic of this exciting evening.
Our panel of experts will weigh in on the future of life sciences. Hear first-hand from two fast-growing US biotech companies how they expanded into Europe, how they stay innovative and attract talent. Learn why Basel, Switzerland has been voted as one of the most innovative locations in Europe, and hear the latest trends for biotech valuation and funding models.Â
Gabriela Guentherodt, Head of Int. Markets & Promotion, BaselArea.swissÂ
Moderator Patrik Frei, CEO Venture Valuation
Rodger Novak, CEO CRISPR Therapeutics AG
Jayson Dallas, CCO Ultragenyx
Mark Ginestro, Principal, Healthcare and Life Sciences Strategy, KPMG
Roger Sawhney, VP, BizDev, Roivant (as of Jan'17) Former Head Strategy, Novartis / Partner, Bain & Co.
This event is organized by BaselArea.swiss Economic Promotion in collaboration with our partners KPMG Switzerland and Venture Valuation.
BaselArea.swiss is the official economic promotion agency for the region of Basel, Switzerland. As a government-funded organization, our services are free of charge. We assist international companies during their site selection process. We access Basel's highly innovative ecosystem, and diligently plan site visits to the Basel region for foreign investors.  We facilitate contacts to experts (legal, tax, recruitment) and government authorities, and we help with finding suitable real estate (office space, lab, production).